Shimizu M, Hara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman S L, Moriwaki H, Mori H
Department of Pathology, Gifu University School of Medicine, Gifu, Japan.
Hepatology. 2001 Mar;33(3):569-76. doi: 10.1053/jhep.2001.22650.
Urokinase-type plasminogen activator (uPA) is implicated in the regulation of hepatic regeneration by activating hepatocyte growth factor (HGF). Here, we investigated its role in the hepatic regeneration after Fas-mediated massive hepatocyte death employing mice deficient in either uPA or its inhibitor, plasminogen activator inhibitor-1 (PAI-1). We measured kinetics of hepatic levels of proliferating cell nuclear antigen (PCNA)-labeling index, plasmin activity, mature HGF, and its phosphorylated receptor, c-Met. In the genetically targeted and wild-type mice, hepatocytes fell into the same extent of apoptosis 6 to 12 hours after an intraperitoneal injection with anti-Fas antibody, as judged from histologic analysis and a histon-DNA enzyme-linked immunosorbent assay (ELISA). In the wild-type mice, mature HGF emerged in the liver 6 hours following anti-Fas injection, and hepatic PCNA-labeling index started to increase following 24 hours and peaked at 48 hours. In the uPA(-/-) mice, emergence of mature HGF was delayed 12 hours and hepatic regeneration peaked at 96 hours. Supplementation with the uPA gene to the uPA(-/-) mice by in vivo lipofection restored hepatic plasmin levels, and improved a delay in the expression of both mature HGF and phosphorylated c-Met, accompanying a normal rate of liver regeneration. In contrast, PAI-1(-/-) mice showed accelerated liver regeneration; mature HGF emerged as early as 3 hours, and PCNA-labeling index increased at 24 hours. This accelerated regeneration was abolished by administration with anti-HGF antibody. These results strongly suggest a physiologic role of uPA in the proteolytic maturation of HGF, and thereby in hepatic regeneration after Fas-mediated massive hepatocyte death.
尿激酶型纤溶酶原激活剂(uPA)通过激活肝细胞生长因子(HGF)参与肝脏再生的调节。在此,我们利用缺乏uPA或其抑制剂纤溶酶原激活剂抑制剂-1(PAI-1)的小鼠,研究了其在Fas介导的大量肝细胞死亡后的肝脏再生中的作用。我们测量了增殖细胞核抗原(PCNA)标记指数、纤溶酶活性、成熟HGF及其磷酸化受体c-Met的肝脏水平动力学。从组织学分析和组蛋白-DNA酶联免疫吸附测定(ELISA)判断,在基因靶向小鼠和野生型小鼠中,腹腔注射抗Fas抗体后6至12小时,肝细胞发生同等程度的凋亡。在野生型小鼠中,抗Fas注射后6小时肝脏中出现成熟HGF,肝脏PCNA标记指数在24小时后开始增加,并在48小时达到峰值。在uPA基因敲除(-/-)小鼠中,成熟HGF的出现延迟12小时,肝脏再生在96小时达到峰值。通过体内脂质转染向uPA(-/-)小鼠补充uPA基因可恢复肝脏纤溶酶水平,并改善成熟HGF和磷酸化c-Met表达的延迟,同时伴随正常的肝脏再生速率。相比之下,PAI-1基因敲除(-/-)小鼠表现出加速的肝脏再生;成熟HGF最早在3小时出现,PCNA标记指数在24小时增加。用抗HGF抗体给药可消除这种加速的再生。这些结果强烈表明uPA在HGF的蛋白水解成熟中具有生理作用,从而在Fas介导的大量肝细胞死亡后的肝脏再生中发挥作用。